These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23389443)

  • 1. Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Network TC
    Nature; 2013 Feb; 494(7438):506. PubMed ID: 23389443
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Cancer Genome Atlas Research Network
    Nature; 2008 Oct; 455(7216):1061-8. PubMed ID: 18772890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.
    Ferreira WAS; Amorim CKN; Burbano RR; Villacis RAR; Marchi FA; Medina TS; Lima MMC; Oliveira EHC
    Braz J Med Biol Res; 2021; 54(3):e9571. PubMed ID: 33470396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma.
    Su CC; Wang MJ; Chiu TL
    Int J Mol Med; 2010 Aug; 26(2):217-24. PubMed ID: 20596601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.
    Abou-El-Ardat K; Seifert M; Becker K; Eisenreich S; Lehmann M; Hackmann K; Rump A; Meijer G; Carvalho B; Temme A; Schackert G; Schröck E; Krex D; Klink B
    Neuro Oncol; 2017 Apr; 19(4):546-557. PubMed ID: 28201779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrins and p53 pathways in glioblastoma resistance to temozolomide.
    Martin S; Janouskova H; Dontenwill M
    Front Oncol; 2012; 2():157. PubMed ID: 23120745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying causal genes and dysregulated pathways in complex diseases.
    Kim YA; Wuchty S; Przytycka TM
    PLoS Comput Biol; 2011 Mar; 7(3):e1001095. PubMed ID: 21390271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
    Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
    J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
    Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
    J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
    de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
    Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.
    Boyrie S; Delmas C; Lemarié A; Lubrano V; Dahan P; Malric L; Luis J; Gilhodes J; Tosolini M; Mouly L; Lehmann M; Toulas C; Cohen-Jonathan Moyal E; Monferran S
    Oncotarget; 2018 Sep; 9(73):33788-33803. PubMed ID: 30333910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated network analysis identifies core pathways in glioblastoma.
    Cerami E; Demir E; Schultz N; Taylor BS; Sander C
    PLoS One; 2010 Feb; 5(2):e8918. PubMed ID: 20169195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of a PPP1CB-ALK fusion with fusion gene amplification in a congenital glioblastoma.
    Zhong Y; Lin F; Xu F; Schubert J; Wu J; Wainwright L; Zhao X; Cao K; Fan Z; Chen J; Lang SS; Kennedy BC; Viaene AN; Santi M; Resnick AC; Storm PB; Li MM
    Cancer Genet; 2021 Apr; 252-253():37-42. PubMed ID: 33341678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.
    Rahane CS; Kutzner A; Heese K
    J Neurooncol; 2019 Jan; 141(1):57-70. PubMed ID: 30414097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique epigenomic landscape defines the characteristics and differentiation potentials of glioma stem cells.
    Yao B; Jin P
    Genome Biol; 2018 Apr; 19(1):51. PubMed ID: 29636115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.
    Ping Y; Deng Y; Wang L; Zhang H; Zhang Y; Xu C; Zhao H; Fan H; Yu F; Xiao Y; Li X
    Nucleic Acids Res; 2015 Feb; 43(4):1997-2007. PubMed ID: 25653168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical control of coherent gene clusters defines the molecular mechanisms of glioblastoma.
    Tsigelny IF; Kouznetsova VL; Jiang P; Pingle SC; Kesari S
    Mol Biosyst; 2015 Apr; 11(4):1012-28. PubMed ID: 25648506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
    Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.